Sage Therapeutics Inc (SAGE)
5.61
+0.61
(+12.20%)
USD |
NASDAQ |
Dec 20, 16:00
5.605
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics Profit Margin (Quarterly): -788.1% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Outset Medical Inc | -97.47% |
| Biogen Inc | 15.76% |
| Johnson & Johnson | 11.99% |
| Lifecore Biomedical Inc | -65.70% |
| Poseida Therapeutics Inc | 28.20% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.20% |
| Return on Assets | -43.07% |
| Return on Invested Capital | -48.20% |
| Gross Profit Margin (Quarterly) | 55.54% |
| Operating Margin (Quarterly) | -852.5% |
| Return on Net Operating Assets | -965.1% |